Lomaira is intended to help obese and overweight patients lose weight. The drug contains phentermine hydrochloride — an appetite suppressor — in a low dose form, which allows patients to take the drug up to three times a day before meals.
Eligible patients will pay no more than 50 cents per tablet through KVK Tech’s Lomaira Lo-Cost Access Program.
Newtown, Pa.-based KVK Tech plans to launch Lomaira by the end of September.
More articles on supply chain:
Valeant defends drug discount program for two heart drugs
Jimmy Kimmel’s EpiPen joke calls out high drug prices at Emmys
4 things to know about generic price spikes
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
